Vivos Therapeutics (VVOS) Depreciation & Amortization - Total (2020 - 2026)
Vivos Therapeutics (VVOS) reported Depreciation & Amortization - Total of $300000.0 for Q1 2026, up 50.0% year-over-year from $200000.0 in Q1 2025, and up 250.0% quarter-over-quarter from -$200000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Depreciation & Amortization - Total (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Depreciation & Amortization - Total data on file, last reported at $300000.0 in Q1 2026.
- Depreciation & Amortization - Total for Q1 2026 came in at $300000.0, up 50.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $800000.0 (up 60.0% YoY), and the FY2025 annual result was $700000.0, up 40.0% from the prior year.
- Depreciation & Amortization - Total improved to $300000.0 in Q1 2026 per VVOS's latest filing, from -$200000.0 in the prior quarter.
- Over five years, Depreciation & Amortization - Total peaked at $400000.0 in Q3 2025 and troughed at -$200000.0 in Q4 2025.
- A 5-year average of $170588.2 and a median of $200000.0 in 2022 frame the typical range for Depreciation & Amortization - Total.
- On a YoY basis, Depreciation & Amortization - Total climbed as much as 300.0% in 2025 and fell as far as 300.0% in 2025.
- A 5-year view of Depreciation & Amortization - Total shows it stood at $300000.0 in 2022, then tumbled by 33.33% to $200000.0 in 2023, then sank by 50.0% to $100000.0 in 2024, then sank by 300.0% to -$200000.0 in 2025, then soared by 250.0% to $300000.0 in 2026.
- Business Quant data shows VVOS's Depreciation & Amortization - Total at $300000.0 in Q1 2026, -$200000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | -200,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 80,597.00 |